Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Hyphens Pharma International Ltd

1J5.SI ✓ COMPLIANT ☆ Track — members

SGX-ST · Healthcare · Pharmaceuticals ·

Singapore Micro Cap Analyst: STRONG BUY

Last Close

$0.29

▲ +0.00%

Market Cap $88.91M · Vol 36.20K

Key Metrics

P/E Ratio

13.30

FWD: 12.08

Market Cap

$88.91M

Micro Cap

Div Yield

4.11%

Semi-annual dividend

EPS Growth

+43.57%

YoY

RSI (14)

54.55

Momentum

Beta

0.16

vs Market

52W High

$0.31

7.19% below

52W Low

$0.24

23.11% above

Volume

36.20K

Avg 215.87K

P/B

1.48

Price-to-book

ROE

8.29%

Return on equity

Free Float

21.34%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Hyphens Pharma International Ltd (1J5.SI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 1J5.SI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+2.82%

+12.31%

+7.35%

YTD

+8.96%

+15.87%

+32.06%

+35.40%

Financials & Valuation

TTM · Annual

Total Revenue	$137.98M
Net Income	$4.76M
Revenue Growth (YoY)	-0.54%
Gross Margin	40.11%
Operating Margin	8.75%
Net Profit Margin	3.45%
ROE	8.29%
ROA · ROIC	6.22% · 7.31%

P/E Ratio	13.30
Forward P/E (FY1)	12.08
PEG Ratio	-0.42
P/S	0.59
P/B	1.48
P/FCF	6.14
EPS Growth	+43.57%
Outstanding Shares	309.20M

Technical Indicators

50-Day SMA	$0.28
200-Day SMA	$0.27
RSI (14)	54.55
Beta	0.16
52-Week High	$0.31
52-Week Low	$0.24

Volume Today	36.20K
Avg Daily Volume (30D)	215.87K
Relative Volume	0.17x
Volatility (10D)	14.98
Volatility (30D)	22.06
Free Float	21.34%

Analyst Consensus

STRONG BUY

Current Price $0.29

Mean Target $0.36

52W Low$0.24 52W High$0.31

Current

Target

$0.24 $0.31

Current Analyst target

+26.03% upside potential · 2 analysts

Identifiers

ExchangeSGX-ST

FIGIBBG00KSQBRN0

ISINSG1EE4000006

CountrySingapore

Sub-IndustryPharmaceuticals Wholesale

Earnings DateNov 12, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MCK McKesson Corp +1.73% CAH Cardinal Health, Inc +1.25% SIG.AX Sigma Healthcare Ltd -0.69% 000963.SZ Huadong Medicine Co Ltd -3.38% HLUN A.CO H Lundbeck A/S +1.23%

Company Profile

Hyphens Pharma International Limited is a Singapore-based specialty pharmaceutical and consumer healthcare company. The Company's principal activities are those of an investment holding company and provision of management services. The Company's segments include Specialty pharma principals, Proprietary brands, and Medical hypermart and digital. The Specialty pharma principals segment is engaged in the business of marketing and selling a range of specialty pharmaceutical products with exclusivity in the relevant ASEAN countries. The Proprietary brands segment is engaged in the business of developing, marketing and selling its own proprietary range of dermatological products and health supplement products. The Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company and its subsidiaries position themselves as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.